Since the enzymes PTP1B, α-glucosidase, and AR (as well as non-enzymatic glycation products known as AGEs) play critical roles in T2DM, much research has been conducted to develop therapeutic inhibitors. Here, AR is linked to type 2 diabetes mellitus.